{
  "actions": [
    {
      "acted_at": "2019-08-02",
      "action_code": "Intro-H",
      "references": [],
      "text": "Introduced in House",
      "type": "action"
    },
    {
      "acted_at": "2019-08-02",
      "action_code": "H11100",
      "committees": [
        "HSIF"
      ],
      "references": [],
      "status": "REFERRED",
      "text": "Referred to the House Committee on Energy and Commerce.",
      "type": "referral"
    },
    {
      "acted_at": "2019-08-05",
      "action_code": "",
      "committees": [
        "HSIF"
      ],
      "references": [],
      "text": "Referred to the Subcommittee on Health.",
      "type": "referral"
    }
  ],
  "amendments": [],
  "bill_id": "hr4158-116",
  "bill_type": "hr",
  "by_request": false,
  "committee_reports": [],
  "committees": [
    {
      "activity": [
        "referral"
      ],
      "committee": "House Energy and Commerce",
      "committee_id": "HSIF"
    },
    {
      "activity": [
        "referral"
      ],
      "committee": "House Energy and Commerce",
      "committee_id": "HSIF",
      "subcommittee": "Subcommittee on Health",
      "subcommittee_id": "14"
    }
  ],
  "congress": "116",
  "cosponsors": [],
  "enacted_as": null,
  "history": {
    "active": false,
    "awaiting_signature": false,
    "enacted": false,
    "vetoed": false
  },
  "introduced_at": "2019-08-02",
  "number": "4158",
  "official_title": "To prohibit price gouging in the sale of drugs.",
  "popular_title": null,
  "related_bills": [
    {
      "bill_id": "s637-116",
      "identified_by": "CRS",
      "reason": "related",
      "type": "bill"
    }
  ],
  "short_title": "Combatting Unreasonable Rises and Excessively High Drug Prices Act",
  "sponsor": {
    "bioguide_id": "P000597",
    "district": "1",
    "name": "Pingree, Chellie",
    "state": "ME",
    "title": "Rep.",
    "type": "person"
  },
  "status": "REFERRED",
  "status_at": "2019-08-02",
  "subjects": [
    "Administrative remedies",
    "Civil actions and liability",
    "Health",
    "Health care costs and insurance",
    "Health care coverage and access",
    "Health programs administration and funding",
    "Inflation and prices",
    "Prescription drugs"
  ],
  "subjects_top_term": "Health",
  "summary": {
    "as": "Introduced in House",
    "asOf": "2019-08-02",
    "date": "2020-08-04T20:01:23Z",
    "text": "Combatting Unreasonable Rises and Excessively High Drug Prices Act or the CURE High Drug Prices Act\n\nThis bill prohibits price gouging by manufacturers of prescription drugs (including a combination of a drug, device, or biological product) that are covered by a federal health care program.\u00a0The bill specifies percentage increases in price at which price gouging\u00a0is presumed."
  },
  "titles": [
    {
      "as": null,
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "CURE High Drug Prices Act",
      "type": "display"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "To prohibit price gouging in the sale of drugs.",
      "type": "official"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "Combatting Unreasonable Rises and Excessively High Drug Prices Act",
      "type": "short"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "CURE High Drug Prices Act",
      "type": "short"
    }
  ],
  "updated_at": "2022-11-01T13:50:11Z",
  "url": "https://www.govinfo.gov/bulkdata/BILLSTATUS/116/hr/BILLSTATUS-116hr4158.xml"
}